BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2006
View Archived Issues
Alpha-defensin treatment for proliferative retinopathy that complicates diabetes and prematurity
Read More
QW-1624F2-2 active against human neuroblastoma in vivo
Read More
Enriched enteral formulation benefits children with lung injury, adults with sepsis
Read More
ImQuest and Samjin form drug development alliance
Read More
Analgesic effects of targeting iNOS in neuropathic and inflammatory pain
Read More
Fast track designation for Phenoptin in PKU
Read More
NicVAX completes phase II dose-ranging study, set for proof-of-concept trial
Read More
Toyama and Astellas sign letter of intent for oral T-3811 in Japan
Read More
Oral iclaprim shows good oral bioavailability
Read More
Rigel to receive milestone payment for R-763
Read More
AeroLEF studied in phase IIb trial for moderate to severe acute pain
Read More
Phase III trial for antidepressant vilazodone
Read More
Phase III pivotal trial protocol submitted for APF-530
Read More
Japanese approval for Abilify
Read More
Eculizumab arrests chronic intravascular hemolysis in PNH patients
Read More
SCH-336: CB2 agonist with potent antiinflammatory activity
Read More
Novel agents imparted for the treatment of arthritis and related disorders
Read More
New compounds for respiratory disorders prepared and tested
Read More
Recent Carlsson and Abbott patents describe new therapeutic agents for anxiety, depression, etc.
Read More
Sutent approved for advanced renal cell carcinoma and malignant GIST
Read More
Exubera approved in Europe and the U.S.
Read More
Positive opinion for Myozyme for Pompe disease in Europe
Read More
Ranexa approved for chronic angina
Read More
Quarterly i.v. Bonviva injection recommended for approval in Europe
Read More
